TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 206 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.

Quarter-by-quarter ownership
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$311
-16.8%
5,1900.0%0.00%
-25.0%
Q2 2023$374
+3.6%
5,190
+5.7%
0.00%0.0%
Q1 2023$361
+10.1%
4,9090.0%0.00%
+33.3%
Q4 2022$328
-99.9%
4,909
-10.6%
0.00%
-50.0%
Q3 2022$473,000
-19.1%
5,489
+5.6%
0.01%0.0%
Q1 2022$585,000
-27.1%
5,2000.0%0.01%
-14.3%
Q4 2021$803,000
+43.4%
5,200
+29.3%
0.01%
+40.0%
Q3 2021$560,000
+180.0%
4,021
+164.4%
0.01%
+150.0%
Q2 2021$200,000
-13.8%
1,5210.0%0.00%0.0%
Q1 2021$232,000
+53.6%
1,5210.0%0.00%0.0%
Q4 2020$151,000
-41.7%
1,521
-44.1%
0.00%
-33.3%
Q3 2020$259,000
-26.4%
2,722
-13.6%
0.00%
-25.0%
Q2 2020$352,000
+53.7%
3,1500.0%0.00%
+33.3%
Q1 2020$229,000
-43.7%
3,150
-19.2%
0.00%
-25.0%
Q4 2019$407,000
+4.9%
3,9000.0%0.00%
-20.0%
Q3 2019$388,000
-17.8%
3,900
-5.8%
0.01%
-16.7%
Q2 2019$472,000
-34.5%
4,140
-27.9%
0.01%
-33.3%
Q1 2019$721,000
-13.4%
5,740
-6.5%
0.01%
-18.2%
Q4 2018$833,000
-52.9%
6,140
-4.7%
0.01%
-47.6%
Q3 2018$1,768,000
+28.5%
6,440
-3.0%
0.02%
+31.2%
Q2 2018$1,376,000
+25.4%
6,6400.0%0.02%
+23.1%
Q1 2018$1,097,000
+35.8%
6,640
+12.5%
0.01%
+44.4%
Q4 2017$808,000
+0.6%
5,9000.0%0.01%
-10.0%
Q3 2017$803,000
+12.2%
5,9000.0%0.01%
+11.1%
Q2 2017$716,000
+7.3%
5,900
-6.3%
0.01%
+12.5%
Q1 2017$667,000
-6.2%
6,300
-10.0%
0.01%
-11.1%
Q4 2016$711,000
-5.8%
7,000
-5.4%
0.01%
-10.0%
Q3 2016$755,000
-14.5%
7,4000.0%0.01%
-16.7%
Q2 2016$883,000
+11.5%
7,4000.0%0.01%
+20.0%
Q1 2016$792,000
+4.3%
7,400
+5.7%
0.01%0.0%
Q4 2015$759,000
+45.4%
7,000
+14.8%
0.01%
+42.9%
Q3 2015$522,000
-15.1%
6,1000.0%0.01%0.0%
Q2 2015$615,000
+30.9%
6,1000.0%0.01%
+40.0%
Q1 2015$470,000
+44.6%
6,1000.0%0.01%
+25.0%
Q4 2014$325,000
+13.2%
6,1000.0%0.00%
+33.3%
Q3 2014$287,000
-24.5%
6,1000.0%0.00%
-25.0%
Q2 2014$380,000
-15.7%
6,100
-9.0%
0.00%
-20.0%
Q1 2014$451,000
+28.1%
6,7000.0%0.01%
+25.0%
Q4 2013$352,0006,7000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders